Archna Bajaj, MD
Assistant Professor of Clinical Medicine (Translational Medicine and Human Genetics)
Physician, Corporal Michael J. Crescenz Philadelphia VA Medical Center
Department: Medicine
Contact information
3400 Spruce Street
Hospital of the University of Pennsylvania
9010 Maloney Building
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
9010 Maloney Building
Philadelphia, PA 19104
Office: 215-662-7197
Publications
Education:
BS (Electrical Engineering)
Union College, 2004.
MS (Electrical Engineering)
Union College, 2005.
MD
Case Western Reserve University School of Medicine, 2012.
MSCE
University of Pennsylvania, 2017.
Permanent linkBS (Electrical Engineering)
Union College, 2004.
MS (Electrical Engineering)
Union College, 2005.
MD
Case Western Reserve University School of Medicine, 2012.
MSCE
University of Pennsylvania, 2017.
Description of Clinical Expertise
lipids, cholesterol, lipid disorders, familial hypercholesterolemia, lipoprotein(a), preventive cardiology, clinical trialsDescription of Research Expertise
lipids, cholesterol, preventive cardiology, clinical trials, lipoprotein(a), familial hypercholesterolemiaSelected Publications
Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, Dave L. Dixon, Keith C. Ferdinand, Samuel S. Gidding, Edward A. Gill, Terry A. Jacobson, Erin D. Michos, Maya S. Safarova, Daniel E. Soffer, Pam R. Taub, Michael J. Wilkinson, Don P. Wilson, Christie M. Ballantyne: A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology Apr 2024.Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR: Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran. JAHA Mar 2024.
Daniel J Rader, Archna Bajaj: Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease? JACC 2023.
Archna Bajaj, Marina Cuchel: From supravalvular to valvular aortic stenosis: are statins contributing tot he phenotypic shift in homozygous familial hypercholesterolemia? European Heart Journal 2022.
Bajaj A, Rader DJ.: Antisense oligonucleotides for atherosclerotic disease. Nat Med 26(4), April 2020.
Bajaj A, Cuchel M.: Homozygous familial hypercholesterolemia: what treatments are on the horizon? Curr Opin Lipidol 31(3), June 2020.
Bajaj A, Ihegword A, Qiu C, Small AM, Wei WQ, Bastarache L, Feng Q, Kember RL, Risman M, Bloom RD, Birtwell DL, Williams H, Shaffer CM, Chen J, Center RG, Denny JC, Rader DJ, Stein CM, Damrauer SM, Susztak K.: Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. Kidney Int 97(5), May 2020.
Bajaj A, Xie D, Cedillo-Couvert E, Charleston J, Chen J, Deo R, Feldman HI, Go AS, He J, Horwitz E, Kallem R, Rahman M, Weir MR, Anderson AH, Rader DJ; CRIC Study Investigators.: Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD. Am J Kidney Dis 73(6), June 2019.
Rader DJ, Bajaj A, Khetarpal SA.: Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk. J Am Coll Cardiol 69: 801-804, Feb 2017.
Bajaj A, Damrauer SM, Anderson AH, Xie D, Budoff MJ, Go AS, He J, Lash JP, Ojo A, Post WS, Rahman M, Reilly MP, Saleheen D, Townsend RR, Chen J, Rader DJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*.: Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Arterioscler Thromb Vasc Biol 37(10), Oct 2017.